Injection site reaction with subcutaneous methotrexate

Dermatol Ther. 2022 May;35(5):e15414. doi: 10.1111/dth.15414. Epub 2022 Mar 5.

Authors

Carlota González-Moure¹, Olalla Figueroa-Silva¹, Olaya Álvarez-García², Pedro Gil-Pallares¹, Sandra Peña-López¹, Teresa Usero-Bárcena¹, Fernando Campo-Cerecedo³, Tomás Ramón Vázquez-Rodríguez⁴, Benigno Monteagudo-Sánchez¹

Affiliations

¹ Department of Dermatology, Complejo Hospitalario Universitario de Ferrol, Ferrol, Spain.
² Department of Allergy, Complejo Hospitalario Universitario de Ferrol, Ferrol, Spain.
³ Department of Pathology, Complejo Hospitalario Universitario de Ferrol, Ferrol, Spain.
⁴ Department of Rheumatology, Complejo Hospitalario Universitario de Ferrol, Ferrol, Spain.

PMID: 35229418
DOI: 10.1111/dth.15414

No abstract available

Publication types

Letter

MeSH terms

Humans
Injection Site Reaction* / diagnosis
Injection Site Reaction* / etiology
Injections, Subcutaneous
Methotrexate* / adverse effects

Substances

Methotrexate